DR. DARRYL WILLETT, M.D.
Medical Practice at Mackenzie Dr, Columbus, OH
License number
Ohio 35063683
Category
Medical Practice
Type
Otolaryngology/Facial Plastic Surgery
Address
Address
1810 Mackenzie Dr, Columbus, OH 43220
Phone
(614) 273-2250
(614) 273-2255 (Fax)
(614) 538-2424
(614) 538-2418 (Fax)
(614) 273-2255 (Fax)
(614) 538-2424
(614) 538-2418 (Fax)
Professional information
Dr. Darryl Willett, Columbus OH - MD (Doctor of Medicine)
Specialties:
Ear, Nose, and Throat
Address:
Ohio ENT Surgeons
974 Bethel Rd STE A, Columbus 43214
(614) 538-2424 (Phone)
Ohio ENT
974 Bethel Rd STE A, Columbus 43214
(614) 538-2424 (Phone)
974 Bethel Rd STE A, Columbus 43214
(614) 538-2424 (Phone)
Ohio ENT
974 Bethel Rd STE A, Columbus 43214
(614) 538-2424 (Phone)
Conditions:
Chronic Sinusitis, Ear Infection, Ear, Nose & Throat (Diseases & Disorders), Hoarseness, Nasal Obstruction, Nasal Polyps, Sinus Problems, Sinusitis, Sleep Apnea, Snoring
Certifications:
Otolaryngology, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Ohio ENT Surgeons
974 Bethel Rd STE A, Columbus 43214
Ohio ENT
974 Bethel Rd STE A, Columbus 43214
Dublin Methodist Hospital
7500 Hospital Ave, Dublin 43016
Nationwide Children's Hospital
700 Dr Children's, Columbus 43205
Riverside Methodist Hospital
3535 Olentangy River Rd, Columbus 43214
974 Bethel Rd STE A, Columbus 43214
Ohio ENT
974 Bethel Rd STE A, Columbus 43214
Dublin Methodist Hospital
7500 Hospital Ave, Dublin 43016
Nationwide Children's Hospital
700 Dr Children's, Columbus 43205
Riverside Methodist Hospital
3535 Olentangy River Rd, Columbus 43214
Education:
Medical School
Ohio State University College Of Medicine and Public Health
Graduated: 1991
Mt Carmel Mc
Graduated: 1992
Ohio State University
Graduated: 1996
Ohio State University College Of Medicine and Public Health
Graduated: 1991
Mt Carmel Mc
Graduated: 1992
Ohio State University
Graduated: 1996
Darryl N Willett, Columbus OH
Specialties:
Otolaryngology, Otolaryngology/Facial Plastic Surgery
Work:
Ohio ENT
974 Bethel Rd, Columbus, OH 43214
974 Bethel Rd, Columbus, OH 43214
Education:
The Ohio State University(1991)
Method For The Stimulation Of Cell Growth And The Inhibition Of Cell Proliferation By The Utilization Of Selenodithiols Such As Selenodiglutathione
US Patent:
5118624, Jun 2, 1992
Filed:
Nov 30, 1989
Appl. No.:
7/443608
Inventors:
Wayne B. Parrish - Columbus OH
Darryl N. Willett - Columbus OH
Francis A. Kralick - Columbus OH
Gregory N. Orr - Westerville OH
Darryl N. Willett - Columbus OH
Francis A. Kralick - Columbus OH
Gregory N. Orr - Westerville OH
Assignee:
The Ohio State University - Columbus OH
International Classification:
C12N 500, C12N 999
US Classification:
4352402
Abstract:
This invention relates to the inhibition of cell proliferation in mammalian host organisms. More particularly the invention relates to the utilization of selenodithiol compositions, particularly selenodiglutathione (GSSeSG) within a narrow concentration range, in which it is both effective as an inhibitor of cancer tumor cell proliferation in mammals, particularly in the prevention of neoplastic cell division in humans, while substantially non toxic outside this narrow range to the treated host organism. The invention also relates to a method for stimulating cellular proliferation at lower concentration of selenodiglutathione.
Method For The Inhibition Of The Proliferation Of Cancer Cells In A Tumor Sensitive To Treatment With A Selenodithiol By The Injection Into The Tumor Of A Selenodithiol Such As Selenodiglutathione
US Patent:
5104852, Apr 14, 1992
Filed:
Jan 22, 1991
Appl. No.:
7/643360
Inventors:
Francis A. Kralick - Columbus OH
Wayne B. Parrish - Columbus OH
Darryl N. Willett - Columbus OH
Wayne B. Parrish - Columbus OH
Darryl N. Willett - Columbus OH
Assignee:
The Ohio State University - Columbus OH
International Classification:
A61K 3714
US Classification:
514 6
Abstract:
The invention discloses a biphasic method of treating cancer tumors sensitive to treatment with selenodithiols, which method comprises administering a specific amount of a selenodithiol to the cancer tumor whereby the cancer tumor cells die and the surrounding non-cancerous tissue exhibits cell proliferation in cells sensitive to selenodithiols. A range of ratios of selenodithiol concentration to tumor diameters or volume is claimed.